{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:11:02Z","timestamp":1778663462016,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160664"],"award-info":[{"award-number":["82160664"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301866"],"award-info":[{"award-number":["82301866"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013072","name":"Major Science and Technology Project of Hainan Province","doi-asserted-by":"publisher","award":["ZDYF2024SHFZ103"],"award-info":[{"award-number":["ZDYF2024SHFZ103"]}],"id":[{"id":"10.13039\/501100013072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022977","name":"Frontiers Science Center for Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["201203"],"award-info":[{"award-number":["201203"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108786","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T16:44:37Z","timestamp":1753116277000},"page":"108786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery and synthesis of azepinoindoles as novel hCYP1B1 inhibitors with AhR-independent anticancer activity"],"prefix":"10.1016","volume":"163","author":[{"given":"Jiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeepraj","family":"Durairaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadana","family":"Sabapathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Qun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108786_bb0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389200023337054","article-title":"The cytochrome P450 superfamily","volume":"3","author":"Danielson","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bioorg.2025.108786_bb0010","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrc2015","article-title":"The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis","volume":"6","author":"Nebert","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108786_bb0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/09298673113206660277","article-title":"Inhibitors and prodrugs targeting CYP1","volume":"21","author":"Cui","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0020","doi-asserted-by":"crossref","first-page":"23847","DOI":"10.1074\/jbc.R400004200","article-title":"Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer","volume":"279","author":"Nebert","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0025","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1210\/en.2003-0192","article-title":"Characterization of the oxidative metabolites of 17\u03b2-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms","volume":"144","author":"Lee","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bioorg.2025.108786_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111938","article-title":"Synthesis and structure-activity relationship studies of \u03b1-naphthoflavone derivatives as CYP1B1 inhibitors","volume":"187","author":"Dong","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0035","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1021\/acs.jmedchem.5b00265","article-title":"Design and synthesis of new \u03b1-naphthoflavones as cytochrome P450 (CYP) 1B1 inhibitors to overcome docetaxel-resistance associated with CYP1B1 overexpression","volume":"58","author":"Cui","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0040","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.2174\/1381612023392784","article-title":"The aryl hydrocarbon receptor in anticancer drug discovery","volume":"8","author":"Bradshaw","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2025.108786_bb0045","first-page":"36","article-title":"Aryl-hydrocarbon receptor as a potential target for anticancer therapy","volume":"13","author":"Vorontsova","year":"2019","journal-title":"Biochem"},{"key":"10.1016\/j.bioorg.2025.108786_bb0050","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tiv.2009.12.002","article-title":"2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin and \u03b2-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism","volume":"24","author":"Zordoky","year":"2010","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bioorg.2025.108786_bb0055","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1039\/C8RA00465J","article-title":"Development of 2-arylbenzo [h] quinolone analogs as selective CYP1B1 inhibitors","volume":"8","author":"Dong","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108786_bb0060","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1124\/dmd.107.015826","article-title":"CYP1A induction and human risk assessment","volume":"35","author":"Ma","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bioorg.2025.108786_bb0065","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/10715760400017319","article-title":"Benzo [a] pyrene, 3-Methylcholanthrene and \u00df-Naphthoflavone induce oxidative stress in hepatoma Hepa 1c1c7 cells by an AhR-dependent pathway","volume":"38","author":"Elbekai","year":"2004","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bioorg.2025.108786_bb0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biopha.2017.08.056","article-title":"Decreased expression of cytochrome p450 1B1 in non-small cell lung cancer","volume":"95","author":"S\u0142owikowski","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108786_bb0075","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1016\/j.bmcl.2017.11.013","article-title":"Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme","volume":"27","author":"Sharma","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108786_bb0080","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2010.01.028","article-title":"Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes","volume":"79","author":"Yamaori","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108786_bb0085","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/tx980090+","article-title":"Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1","volume":"11","author":"Shimada","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108786_bb0090","first-page":"173","article-title":"Peter, cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies","volume":"523","author":"Guengerich","year":"2003","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.bioorg.2025.108786_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/tx010151v","article-title":"Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7, 12-dimethylbenz [a] anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation","volume":"15","author":"Kleiner","year":"2002","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108786_bb0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.105.007849","article-title":"Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450","volume":"34","author":"Ueng","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bioorg.2025.108786_bb0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/tx2004163","article-title":"Inhibition of cytochrome p450 enzymes by quinones and anthraquinones","volume":"25","author":"Sridhar","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108786_bb0110","first-page":"177","article-title":"CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1\/CYP1B1 inhibitors, European","volume":"131","author":"Sonawane","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.108786_bb0115","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2174\/1389557511313090010","article-title":"Structure, chemistry and pharmacology of naphthoflavones","volume":"13","author":"Cui","year":"2013","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0120","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1021\/acs.jmedchem.8b01633","article-title":"Design, synthesis, and biological evaluation of cytochrome P450 1B1 targeted molecular imaging probes for colorectal tumor detection","volume":"61","author":"Meng","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmech.2017.02.032","article-title":"Quinazoline derivatives as selective CYP1B1 inhibitors","volume":"130","author":"Siddique","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115552","article-title":"Discovery of 4\u2032-trifluoromethylchalcones as novel, potent and selective hCYP1B1 inhibitors without concomitant AhR activation","volume":"258","author":"Wu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tibs.2020.03.004","article-title":"Natural compounds as pharmaceuticals: the key role of cytochromes P450 reactivity","volume":"45","author":"Di Nardo","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bioorg.2025.108786_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114845","article-title":"An overview of aryl hydrocarbon receptor ligands in the last two decades (2002\u22122022): a medicinal chemistry perspective","volume":"244","author":"Lin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0145","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/acs.jmedchem.2c01368","article-title":"Design of cytochrome P450 1B1 inhibitors via a scaffold-hopping approach","volume":"66","author":"Hachey","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0150","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.bmcl.2016.05.064","article-title":"Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1","volume":"26","author":"Lee","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108786_bb0155","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1021\/ol060348k","article-title":"Arboflorine, an unusual pentacyclic monoterpenoid indole alkaloid incorporating a third nitrogen atom","volume":"8","author":"Lim","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108786_bb0160","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1021\/jm070246f","article-title":"New sst4\/5-selective somatostatin peptidomimetics based on a constrained tryptophan scaffold","volume":"50","author":"Feytens","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0165","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1021\/jm900476c","article-title":"Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors","volume":"52","author":"Putey","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0170","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0960-894X(98)00138-3","article-title":"Azepinoindole derivatives with high affinity for brain dopamine and serotonin receptors","volume":"8","author":"Maryanoff","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108786_bb0175","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/jm040013d","article-title":"Inhibition of cytokine production by hymenialdisine derivatives","volume":"47","author":"Sharma","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1021\/ml100230n","article-title":"Synthesis and structure\u2212activity relationships of benzothienothiazepinone inhibitors of protein kinase D","volume":"2","author":"Bravo-Altamirano","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108786_bb0185","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1021\/acs.orglett.8b00346","article-title":"Pd-catalyzed divergent C (sp2)\u2013H activation\/cycloimidoylation of 2-Isocyano-2, 3-diarylpropanoates","volume":"20","author":"Tang","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108786_bb0190","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/acs.joc.2c00717","article-title":"Synthesis of azepinoindoles via Pd-catalyzed C (sp2)\u2013H imidoylative cyclization reactions","volume":"87","author":"Wang","year":"2022","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/ijms17020213","article-title":"Active site mutations as a suitable tool contributing to explain a mechanism of aristolochic acid I nitroreduction by cytochromes P450 1A1, 1A2 and 1B1","volume":"17","author":"Milichovsk\u00fd","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108786_bb0200","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/dmd.119.086892","article-title":"Nitidine chloride\u2013induced CYP1 enzyme inhibition and alteration of estradiol metabolism","volume":"47","author":"Mao","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bioorg.2025.108786_bb0205","doi-asserted-by":"crossref","first-page":"28324","DOI":"10.1074\/jbc.271.45.28324","article-title":"Isolation and characterization of the human cytochrome P450 CYP1B1 gene","volume":"271","author":"Tang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0210","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1080\/07391102.2021.1905552","article-title":"Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1","volume":"40","author":"Raju","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108786_bb0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpba.2016.01.022","article-title":"A high throughput solubility assay for drug discovery using microscale shake-flask and rapid UHPLC\u2013UV\u2013CLND quantification","volume":"122","author":"Lin","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2025.108786_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112895","article-title":"Discovery of heterocycle-containing \u03b1-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors","volume":"209","author":"Dong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0225","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","article-title":"ADMET modeling approaches in drug discovery","volume":"24","author":"Ferreira","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.108786_bb0230","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108786_bb0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2025.108786_bb0240","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/em.21885","article-title":"Emerging approaches in predictive toxicology","volume":"55","author":"Zhang","year":"2014","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.bioorg.2025.108786_bb0245","series-title":"Food for Thought: Green Toxicology","author":"Maertens","year":"2014"},{"key":"10.1016\/j.bioorg.2025.108786_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12302-017-0115-z","article-title":"Green toxicology: a strategy for sustainable chemical and material development","volume":"29","author":"Crawford","year":"2017","journal-title":"Environ. Sci. Eur."},{"key":"10.1016\/j.bioorg.2025.108786_bb0255","first-page":"1","article-title":"Collaborative development of predictive toxicology applications","volume":"2","author":"Hardy","year":"2010","journal-title":"J. Heminform."},{"key":"10.1016\/j.bioorg.2025.108786_bb0260","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/wcms.1240","article-title":"In silico toxicology: computational methods for the prediction of chemical toxicity","volume":"6","author":"Raies","year":"2016","journal-title":"Comp. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108786_bb0265","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.108786_bb0270","doi-asserted-by":"crossref","first-page":"D295","DOI":"10.1093\/nar\/gkn850","article-title":"SuperToxic: a comprehensive database of toxic compounds","volume":"37","author":"Schmidt","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.108786_bb0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1568009620666201006143419","article-title":"The activation of procarcinogens by CYP1A1\/1B1 and related chemo-preventive agents: a review","volume":"21","author":"Li","year":"2021","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bioorg.2025.108786_bb0280","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.toxlet.2022.11.014","article-title":"Human CYP1B1 enzyme-mediated, AhR enhanced activation of aflatoxin B1 for its genotoxicity in human cells","volume":"373","author":"Chen","year":"2023","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bioorg.2025.108786_bb0285","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/mutage\/gen035","article-title":"Reactive oxygen species from the uncoupling of human cytochrome P450 1B1 may contribute to the carcinogenicity of dioxin-like polychlorinated biphenyls","volume":"23","author":"Green","year":"2008","journal-title":"Mutage"},{"key":"10.1016\/j.bioorg.2025.108786_bb0290","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41467-023-35958-7","article-title":"scm6A-seq reveals single-cell landscapes of the dynamic m6A during oocyte maturation and early embryonic development","volume":"14","author":"Yao","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:31:32Z","timestamp":1778661092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":58,"alternative-id":["S0045206825006662"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108786","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and synthesis of azepinoindoles as novel hCYP1B1 inhibitors with AhR-independent anticancer activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108786"}}